TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

The Worst Biotech CEO of 2012 Is...

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Your Vote Counts: Who Is the Worst Biotech CEO of 2012?

The Next Big Thing in Biotech: Worst CEO Candidates
VIDEO

The Next Big Thing in Biotech: Worst CEO Candidates

Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers
MARKETS

4 Biotech Stocks Under $10 Soaring Higher

Buy Rated Semiconductors Lag the SOX
MARKETS

5 Biotech Stocks Under $5 Blasting Off

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

BioSante Execs Use Failed Libigel To Keep Paychecks Rolling In

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Biosante Stock Gaps Down On Today's Open (BPAX)

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stock Mailbag: Vivus, Chelsea, BioCryst

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

These Drugs Stocks Will Win FDA Approval

Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
STOCKS

BioSante: A Penny Stock Still Overvalued

5 Stocks Set to Soar on Bullish Earnings
INVESTING

5 Stocks Poised for Breakouts

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

6 Drug Stocks Unworthy of Biotech Bull Market

AirMedia Group (AMCN) In A Perilous Reversal
MARKETS

Biosante Stock Falls On Unusually High Volume (BPAX)

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Play TheStreet's FDA Drug-Approval Contest

Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
STOCKS

27 Hot Drugs Facing FDA Approval in 2012

Dating Sites: Best, Worst & Weirdest
INVESTING

Biotech Stock Live Chat: 2012 Preview

Dating Sites: Best, Worst & Weirdest
OPINION

Market Preview: The Year Without a Santa Claus Rally

Dating Sites: Best, Worst & Weirdest
OPINION

Novellus, BioSante: After-Hours Trading

3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Biosante Stock Falls On Unusually High Volume (BPAX)

Steve Rosenman Says Amarin Has Sticky Web Eyeballs!
STOCKS

BioSante Pharma Readying Release of 'Female Viagra' Study Results

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

22 Hot Drugs Facing FDA Approval in 2012

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

10 Most Shorted Stocks in Biotech

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Orexigen: Contrave's Odds Still Slim